CMG Pharmaceutical Co., Ltd. (KOSDAQ: 058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,100.00
+50.00 (2.44%)
Sep 12, 2024, 9:47 AM KST
-22.94%
Market Cap 284.73B
Revenue (ttm) 93.19B
Net Income (ttm) 8.28B
Shares Out 138.89M
EPS (ttm) 50.27
PE Ratio 40.78
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 75,077
Open 2,055.00
Previous Close 2,050.00
Day's Range 2,055.00 - 2,105.00
52-Week Range 1,847.00 - 2,830.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 277
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.